Senior insider sale
VANDA PHARMACEUTICALS INC. — senior position signals high conviction
$240.9K
30K shares
What this filing means
HONORE TAGE plans to sell 30K shares of VANDA PHARMACEUTICALS INC. valued at approximately $240.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001193125-26-064742
30K
Shares to sell
$240.9K
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Vesting / Settlement of Restricted Stock Units
Compensation
3/15/2025
6.09KVesting / Settlement of Restricted Stock Units
Compensation
6/8/2024
17.31KVesting / Settlement of Restricted Stock Units
Compensation
3/15/2024
6.60KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2025 | Vesting / Settlement of Restricted Stock Units Compensation | 6.09K | — |
6/8/2024 | Vesting / Settlement of Restricted Stock Units Compensation | 17.31K | — |
3/15/2024 | Vesting / Settlement of Restricted Stock Units Compensation | 6.60K | — |
| Total | 30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
30K
Market value
$240.9K
2/23/2026
Total
Units
30K
Value
$240.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 30K | $240.9K | NASDAQ | Planned |
| Total | 30K | $240.9K | ||